Zobrazeno 1 - 10
of 1 040
pro vyhledávání: '"Systemic embolism"'
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 18, Iss 1, Pp 1-5 (2023)
Abstract Background A silent left ventricular thrombus is dangerous. The current standard anticoagulation therapy was ineffective in our case or similar, and the outcome was poor. Case presentation A 33-year-old man with a silent left ventricular thr
Externí odkaz:
https://doaj.org/article/784cc5bc5e5348e4bde1e0f975ff80cf
Autor:
Yasuo Terauchi, Hiroshi Inoue, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Takanori Ikeda, Yukihiro Koretsune, Ken Okumura, Shinya Suzuki, Hiroyuki Tsutsui, Kazunori Toyoda, Atsushi Hirayama, Masahiro Yasaka, Takenori Yamaguchi, Satoshi Teramukai, Tetsuya Kimura, Yoshiyuki Morishima, Atsushi Takita, Wataru Shimizu
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Background This ANAFIE Registry sub-analysis investigated 2-year outcomes and oral anticoagulant (OAC) use stratified by glycated hemoglobin (HbA1c) levels among Japanese patients aged ≥ 75 years with non-valvular atrial fibrillation (NVAF
Externí odkaz:
https://doaj.org/article/43e81d6124704618a11c2c5a40efbc2c
Autor:
Ahmad Alayyat, Munir Zaqqa, Ayman Hammoudeh, Daria Jaarah, Mohammad Bahhour, Mohammed Nawaiseh, Imad Alhaddad
Publikováno v:
American Journal of Medicine Open, Vol 10, Iss , Pp 100058- (2023)
Introduction: Direct oral anticoagulant agents (DOACs) are indicated for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). Reduced doses of DOACs are indicated in patients who have renal impairment and according to age and we
Externí odkaz:
https://doaj.org/article/afca2fa41ce94020a876b0330881a886
Publikováno v:
Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām, Vol 31, Iss 1, Pp 13-18 (2023)
Introduction: The aortic valve has usually three cusps. The aortic valve regulates blood flow, and it opens to let blood flow from the left ventricle to the aorta (systole), and it closes to prevent blood from flowing in the wrong direction (diastole
Externí odkaz:
https://doaj.org/article/f79cb4dc6d0f4699b92f9bcf9f8214c0
Publikováno v:
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 25, Iss 1, Pp 188-194 (2023)
Background and Objective: Systemic embolism can be one of the unfortunate side effects of left ventricular thrombus following acute heart infarction, and its timely diagnosis and treatment is very important. In this report, a patient with saddle embo
Externí odkaz:
https://doaj.org/article/41365df7ed0a4cf883db04bf68d1967c
Autor:
Tamara Kovačević Preradovic, Siniša Miljković, Ljiljana Kos, Aziz Šukalo, Una Glamočlija, Amna Tanović Avdić, Meliha Mehić
Publikováno v:
Journal of the Practice of Cardiovascular Sciences, Vol 9, Iss 2, Pp 110-115 (2023)
Context: Rivaroxaban is an oral direct factor Xa inhibitor reducing the risk of systemic embolism and stroke in patients with nonvalvular atrial fibrillation. Aims: The primary objective was to evaluate the effectiveness of rivaroxaban therapy in red
Externí odkaz:
https://doaj.org/article/721a72b08bea41cdbd3db00a7e96b551
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Lipids in Health and Disease, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background Lipoprotein(a) [Lp(a)] is a recognized risk factor for ischemic stroke (IS); however, its role in thromboembolism in patients with non-valvular atrial fibrillation (NVAF) remains controversial. We aimed to assess the association o
Externí odkaz:
https://doaj.org/article/c7257e06e10f416b96e764a377fc611b